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Abstract
Ipercaloric diet and reduced physical activity have driven the rise in the prevalence of childhood obesity over a 
relatively short time interval. Family and twin studies have led to the conclusion that the strong predicitve value of 
parental body mass index (BMI) mainly stems from genetic rather than environmental factors. Whereas the common 
polygenic obesity arises when an individual genetic make-up is susceptible to an environment that promotes energy 
consumption over energy expenditure, monogenic obesity, on the contrary, is the obesity associated with a single 
gene mutation, which is sufficient by itself to cause weight gain in a food abundant context. Genes involved in the 
leptin-melanocortin pathway are often mutated in these cases. The cumulative prevalence of monogenic obesity 
among children with severe obesity is about 5%.
Recently, deletions in the region p11.2 of the chromosome 16 encompassing the gene SH2B1, which is involved in the 
leptin and insulin signaling, have been reported in about 0.5% of children with severe early-onset obesity. These 
patients show extreme hyperphagia, severe insulin resistance and, in some cases, mild developmental delay.
Introduction
Childhood obesity appears particularly alarming consid-
ering the strong association with increased rates of pre-
mature death from endogenous causes observed in a
cohort of American children followed for more than 20
years [1].
Ipercaloric diet and reduced physical activity have
driven the rise in the prevalence of adult and childhood
obesity over a relatively short time interval [2,3]. The
genetic contribution to body weight has been established
through family studies investigating parent-offspring
relationships and the study of twins and adopted chil-
dren. These studies have led to the conclusion that the
strong predictive value of parental body mass index
(BMI) mainly stems from genetic rather than environ-
mental factors. Twin studies, in comparison to family and
adoption studies, have revealed that between 40 and 70%
of the BMI variance within a population can be expalined
by genetic effects [4-6].
The molecular approach has revealed several candidate
genes for the human obesity and has cleary positioned
interactions between genetic make-up and enviroment to
understand the mechanisms involved in fat-mass expan-
sion [7-9].
Considering the genetic point of view obesity is classi-
fied in i) monogenic obesity, that is the obesity associated
with a single gene mutation; in these cases single gene
variants are sufficient by themselves to cause obesity in
food abundant societies; patients with monogenic obesity
usually show extremely severe phenotypes characterized
by childhood obesity onset, often associated with addi-
tional behavioral, developmental or endocrine disorders
[10,11]; ii) syndromic obesity (this includes some Mende-
lian disorders in wich patients are clinically obese and are
additionally distinguished by mental retardation, dys-
morfic features, and organ-specific developmental abnor-
malities) [12] and iii) polygenic obesity; this very
common kind of obesity, which concerns the great major-
ity of obese children, arises when an individual genetic
make-up is susceptible to an environment that promotes
energy consumption over energy expenditure [13].
The study of extreme human obesity caused by single
gene defects has provided a glimpse into the long-term
regulation of body weight and has shown that the hypo-
thalamic leptin-melanocortin system is critical for energy
balance in humans, because disruption of this pathway
causes the most severe obesity phenotypes. Briefly, leptin
is an adipocyte-derived satiety hormone that signals the
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Page 2 of 3size of the fat depot interacting with the leptin receptor in
the nucleus arcuatus of the hypothalamus. The signal is
then forwarded via the alpha-melanocyte stimulating
hormone to the melanocortin-4 receptor allowing appe-
tite suppression and increasing energy expenditure.
Mutations in genes involved in this pathway accounts for
not more than 5% of all childhood severe obesity cases
(Table 1). In fact, whereas mutations of the leptin (LEP)
and proopiomelanocortin (POMC) genes are rare [14,15],
both mutations of the melanocortin-4 receptor (MC4R)
and of the leptin receptor (LEPR) genes have been
reported in about 2-3% of the children with severe obe-
sity [16,17].
Discussion
In the last years it has been discovered that genetic differ-
ences among people can derive from lost or duplicated
segments of chromosomes, called copy number variants
(CNVs) [18].
A recent work of Farooqi et al analyzed the genomes of
300 obese children for missing or duplicated chromo-
some segments [19]. All patients had severe obesity
defined as a BMI standard deviation score >3, obesity
onset before 10 years of age and 143 of them also showed
developmental delay. Mutations in LEPR, POMC and
MC4R genes were previously excluded by direct nucle-
otide sequencing. A number of CNVs were more com-
mon in the obese children than in a group of normal-
weight controls (p = 0.0005). The commonest CNV found
in these patients was identified in five unrelated children
harbouring overlapping deletions on chromosome
16p11.2. In three patients this deletion co-segregated
with severe obesity, whereas in the remaining two chil-
dren the deletion occurred de novo and was particularly
large, extending through a region previously associated
with autism and mental retardation. Interestingly, both
patients had mild developmental delay in addition to
severe obesity. Pooling the data obtained in a replication
cohort of 1062 Caucasian obese patients with those from
the original discovery set, the prevalence of chromosome
16p11.2 deletions associated to severe early-onset obesity
alone (i.e.; without developmental delay) was 0.41%. The
same kind of deletion was found in only 2 out of 7366
controls (p < 0.001).
All these deletions encompass several genes, some of
them involved in neurological disorders or immunity, but
include also the gene SH2B1, which is known to be
involved in insulin signaling [20]. Mice lacking this gene
become extremely fat and develop hyperphagia, insulin
resistance, hepatic steatosis and type 2 diabetes [21,22].
Furthermore, SH2B1 is a key intermediary in leptin sig-
naling, promoting the activation of the leptin signaling
pathway downstream of JAK2 [23-25]. Additionally, neu-
ron-specific overexpression of SH2B1 in obese mice, pro-
tects against diet-induced leptin and insulin resistance
[26].
Accordingly, the phenotype of the children with
SH2B1-containing deletions is characterized by extreme
hyperphagia and fasting insulin levels disproportionately
elevated compared to age and obesity-matched controls
[19].
Similar data (i.e.; deletions on chromosome 16p11.2)
have been reported in a population prevalently made up
by adults with severe obesity, further demonstrating the
potential importance in common diseases of rare variants
with strong effects [27].
Conclusions
The progress in the knowledge of the human genome and
the discovery of new genetic disorders allowed to catego-
Table 1: Childhood early-onset monogenic obesity due to the involvement of the genes belonging to the leptin-melanocortin pathway.
GENE CHROMOSOME INHERITANCE PREVALENCE PHENOTYPIC FEATURES
LEP 7q31.1 Recessive Rare Severe obesity, Hyperphagia, Hypogonadotropic hypogonadism, 
Central hypothyroidism.
LEPR 1p31 Recessive 1.5% Severe obesity, Hyperphagia, Hypogonadotropic hypogonadism and 
central hypothyroidism (in some cases)
POMC 2p23.3 Recessive Rare Severe obesity, Hyperphagia, Hypothyroidism, ACTH deficiency, Red 
hair (among Caucasians), Increased growth.




16p11.2 Dominant or 
de novo
0.5% Severe obesity, Hyperphagia and severe insulin resistance 
disproportionate for the degree of obesity, Mild developmental delay 
(in some cases).
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Page 3 of 3rize the human obesity as a medical condition rather than
simply a moral failing.
The clinical evaluation of the severely obese children is
becoming increasingly sophisticated. There are a lot of
genes that can be implicated in the obesity and obese
patients in the world are too much to perform molecular
study for everyone. It would be useful to identify particu-
lar phenotypes and clinical features that can help to rec-
ognize the subjects to investigate with genetic screening.
The presence of severe obesity in a young child (<5 yr old)
associated to extreme hyperphagia, severe insulin resis-
tance disproportionate for the degree of obesity and a
positive family history of early-onset obesity may support
a genetic analysis. The cumulative prevalence of mono-
genic obesity among children with severe obesity is not
more than 5% (Table 1). Nevertheless, considering the
great proportion of obese children worldwide [28], the
possibility exists that in countries such as Italy, many
thousands of children might be carriers of this kind of
mutations.
In conclusion, the work of Farooqi et al reports the first
rare CNVs associated with obesity, suggests a role for
SH2BI in human energy homeostasis and glucose metab-
olism and adds another important contribution to the
understanding of the complicated puzzle of the genetic
basis of early onset obesity.
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